Table 3.
Mutant | ||||||
---|---|---|---|---|---|---|
Control Wnt1-Cre; Foxd3flox/− |
Wnt1-Cre; Pax3Sp/+; Foxd3flox/− |
Wnt1-Cre; Pax3Sp-d/+; Foxd3flox/− |
||||
Alive/total | % Alive |
Alive/total | % Alive |
Alive/total | % Alive |
|
11.5 dpc | 8/8 | 100 | 2/3 | 67 | 2/2 | 100 |
12.5 dpc | 10/10 | 100 | 3/5 | 60 | 3/6 | 50 |
13.5 dpc | 7/7 | 100 | 1/7 | 14 | 1/6 | 17 |
≥ 14.5 dpc | 19/19 | 100 | 0/13 | 0 | 0/18 | 0 |
Deletion of Foxd3 from the NC in two independent Pax3 heterozygous mutant backgrounds resulted in midgestational lethality and a 100% penetrant persistent truncus arteriosus, independent of Cre line. All mutant embryos examined had a PTA.